Objectives: The aim of this study was to determine the risk of scaffold thrombosis (ST) after
percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable …

The advent of intracoronary stents has greatly increased the safety and applicability of
percutaneous coronary interventions. One of the drawbacks of drug-eluting stents (DES) is …

Background Recent reports suggest an elevated incidence of bioresorbable vascular
scaffold (BVS) thrombosis (scaffold thrombosis [ScT]). Objectives This study investigated …

Aims: Next to patient characteristics, the lack of a standardised approach for bioresorbable
vascular scaffold (BVS) implantation is perceived as a potential explanation for the …

Background—Acute thrombogenicity and re-endothelialization represent clinically relevant
end points pertaining to the safety of coronary stents, which have not been compared among …

Bioresorbable scaffolds have the potential to introduce a paradigm shift in interventional
cardiology, a true anatomical and functional “vascular restoration” instead of an artificial stiff …

Objectives: The study sought to investigate the incidence, characteristics, predictors, and
possible mechanisms of early and 3-year coronary scaffold thrombosis (ScT). Background …

Objective of this study was to assess the clinical performance of bioresorbable vascular
scaffold (BVS) compared to everolimus-eluting stent (EES) in subjects with ST-segment …

Today, drug-eluting metal stents are considered the gold standard for interventional
treatment of coronary artery disease. While providing inhibition of neointimal hyperplasia …

Objectives: The aim of this study was to assess the feasibility and clinical results following a
pre-specified bioresorbable scaffold (Absorb BVS) implantation strategy in patients with ST …